Ranolazine Tablet, Film Coated, Extended Release
Product Images NDC 70625-207

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Ranolazine (NDC 70625-207). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sungen Pharma Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1000mg-500ct (1000mg 500ct)

NDC 70625-207-02 is a medication called Ranolazine, prescribed as extended-release tablets in a dosage that needs to be determined by a medical practitioner. The tablets should be swallowed whole and not broken, chewed or crushed. Each tablet contains 1000mg of Ranolazine and bottles of 500 tablets are not for home use. It is distributed by Praxgen Pharmaceuticals, LLC, and needs to be stored between 15°C to 30°C (59°F to 86°F). The package insert provides information on dosage and administration.*

FDA Label Image

1000mg-60ct (1000mg 60ct)

This is a description of an FDA-approved medication called Ranolazine, which comes in an extended-release tablet form. The medication contains 1000mg of ranolazine and is manufactured by Cpraxgen Pharmaceuticals LLC. The tablets must be stored at room temperature (25°C/77°F) and should only be taken as directed by a healthcare professional. The package insert must be consulted for information on proper dosage. The tablets must be swallowed whole and should not be crushed, chewed or broken. The medication is available by prescription only.*

FDA Label Image

500mg-500ct (500mg 500ct)

This is a prescription drug named Ranolazine available in an extended-release tablet form. Each tablet contains 500mg of Ranolazine. The tablets should be swallowed as a whole and not crushed, chewed or broken. The drug needs to be stored at a temperature between 25°C to 30°C. The typical dosage should be followed as per the package insert. These tables are not for household use. The drug is distributed by Praxgen Pharmaceuticals LLC.*

FDA Label Image

500mg-60ct (500mg 60ct)

NDC 70625-206-01 is a prescription drug in the form of extended-release tablets of Ranolazine, which are intended to be swallowed whole and not crushed, broken, or chewed. Each tablet has a dosage of 500mg of ranolazine. The tablets come in a container with 60 tablets and should be stored at a temperature of 25°C (77°F) with limited excursions permitted between 15°C to 30°C (SS°F to 86°F). The drug's standard dosage is available in the package insert for dosage and administration. Praxgen Pharmaceuticals LLC, located in Princeton, NJ 08540, distributes the medication.*

FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.